Literature DB >> 19112578

Endometrial and follicular development following letrozole intervention in unexplained infertile patients failed to get pregnant with clomiphene citrate.

Fatemeh Gatreh Samani1, Laya Farzadi, Nariman Nezami, Mohammad Kazem Tarzamni, Fatemeh Soleimani.   

Abstract

PURPOSE: This study is designed to evaluate and compare follicular phase parameters during ovarian stimulation with the clomiphene citrate (CC) and letrozole (LET) in unexplained infertile patients who failed to get pregnant following frequent CC-treated cycles.
METHODS: A total of 64 unexplained infertile women who failed to get pregnant following frequent CC-treated cycles were studied for one CC-treated cycle (100 mg/day), 2 washout cycles, and then 1 LET-treated cycle (5 mg/day). Number of follicles over 14 mm in diameter, diameter of the largest follicles, endometrial thickness, serum estradiol (E2) and LH levels were measured when one mature follicle over 18 mm in diameter detected during transvaginal ultrasonography.
RESULTS: The mean value of the largest follicle diameter, number of developed follicles >14 mm, endometrial thickness and LH in LET-treated cycle was significantly higher than CC-treated cycle (P values were 0.007, <0.001, <0.001, and 0.004, respectively), whereas mean level of E2 showed a significantly lower level during LET-treated cycle (P < 0.001).
CONCLUSIONS: About 5 mg/day of LET is associated with better follicular phase parameters, endometrial development, serum E2 and LH levels in women with unexplained infertility who failed to get pregnant following frequent CC-treated cycles.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19112578     DOI: 10.1007/s00404-008-0888-9

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  7 in total

Review 1.  Clinical review: The use of aromatase inhibitors for ovulation induction and superovulation.

Authors:  Mary Ellen Pavone; Serdar E Bulun
Journal:  J Clin Endocrinol Metab       Date:  2013-04-12       Impact factor: 5.958

2.  Oral Drugs for Unexplained Infertility.

Authors:  Gautam N Allahbadia
Journal:  J Obstet Gynaecol India       Date:  2015-11-13

3.  Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility.

Authors:  Michael P Diamond; Richard S Legro; Christos Coutifaris; Ruben Alvero; Randal D Robinson; Peter Casson; Gregory M Christman; Joel Ager; Hao Huang; Karl R Hansen; Valerie Baker; Rebecca Usadi; Aimee Seungdamrong; G Wright Bates; R Mitchell Rosen; Daniel Haisenleder; Stephen A Krawetz; Kurt Barnhart; J C Trussell; Dana Ohl; Yufeng Jin; Nanette Santoro; Esther Eisenberg; Heping Zhang
Journal:  N Engl J Med       Date:  2015-09-24       Impact factor: 91.245

Review 4.  Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.

Authors:  Sebastian Franik; Quang-Khoi Le; Jan Am Kremer; Ludwig Kiesel; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2022-09-27

5.  Emulating a target trial of the comparative effectiveness of clomiphene citrate and letrozole for ovulation induction.

Authors:  Jennifer J Yland; Yu-Han Chiu; Paolo Rinaudo; John Hsu; Miguel A Hernán; Sonia Hernández-Díaz
Journal:  Hum Reprod       Date:  2022-04-01       Impact factor: 6.918

Review 6.  Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome.

Authors:  Sebastian Franik; Stephanie M Eltrop; Jan Am Kremer; Ludwig Kiesel; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2018-05-24

7.  Super-critical fluid extract of Bryonopsis laciniosa (Shivlingi) seeds restores fertility in zebrafish models through revival of cytological and anatomical features.

Authors:  Acharya Balkrishna; Pradeep Nain; Monali Joshi; Brijesh Kumar; Anurag Varshney
Journal:  J Ovarian Res       Date:  2022-04-27       Impact factor: 5.506

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.